Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1218199

King Street Capital Management, L.P.

Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$189.7M
Reported positions
6
Holdings vs S&P 500, 3 yrs
—
Assets under management
$34.6B

King Street Capital Management, L.P. is a hedge fund that reported 6 positions worth $189.7M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Surgery Partners Inc (SGRY, 53.7%), iShares Broad USD High Yield Corporate B (USHY, 19.5%), Ishares Tr (HYG, 10.0%).

King Street Capital Management, L.P. holdings all 6 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

King Street Capital Management, L.P. 13F holdings
Stock% of 13F valueShare changeReported value
SGRYSurgery Partners Inc53.7%-40.8%$101.8M
USHYiShares Broad USD High Yield Corporate B19.5%—$37.0M
HYGIshares Tr10.0%—$19.0M
TLNTalen Energy Corp9.5%+0.0%$18.1M
VSTVistra Corp4.9%+0.0%$9.4M
ATUSOptimum Communications Inc2.4%-61.1%$4.5M

What King Street Capital Management, L.P. bought and sold in Q2 2026, against Q1 2026.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
-18.9% /yr
S&P 500 +20.1%
3 years
—
5 years
-12.4% /yr
S&P 500 +8.1%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$189.7M6
Q1 2026$328.0M11
Q4 2025$610.8M11
Q3 2025$618.4M14
Q2 2025$486.5M8
Q1 2025$470.9M9
Q4 2024$426.7M11
Q3 2024$113.0M8
Q2 2024$37.6M5
Q2 2023$50.8M8
Q1 2023$19.0M5
Q4 2022$391.5M12

Questions about King Street Capital Management, L.P.'s portfolio

What stocks does King Street Capital Management, L.P. own?

King Street Capital Management, L.P.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 6 positions worth $189.7M. The largest are Surgery Partners Inc (SGRY) at 53.7%, iShares Broad USD High Yield Corporate B (USHY) at 19.5%, Ishares Tr (HYG) at 10.0%, Talen Energy Corp (TLN) at 9.5% and Vistra Corp (VST) at 4.9%.

What did King Street Capital Management, L.P. buy last quarter?

In Q2 2026, King Street Capital Management, L.P. added a new position in iShares Broad USD High Yield Corporate B (USHY) and a new position in Ishares Tr (HYG), compared with its Q1 2026 filing.

What did King Street Capital Management, L.P. sell last quarter?

In Q2 2026, King Street Capital Management, L.P. sold all of Boeing Co (BA), sold all of Blackstone Secd Lending Fd (BXSL), sold all of Uwm Holdings Corporation (UWMC), sold all of Uniti Group LLC (UNIT), sold all of Select Sector Spdr Tr (XLI), Optimum Communications Inc (ATUS) (-61.1% shares) and Surgery Partners Inc (SGRY) (-40.8% shares), compared with its Q1 2026 filing.

When is King Street Capital Management, L.P.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. King Street Capital Management, L.P.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does King Street Capital Management, L.P. manage?

King Street Capital Management, L.P. reported $34.6B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $189.7M.